FDA.reportPublic FDA data

carbidopa

RxCUI
2019
RxNorm name
carbidopa
Term type
IN
Status
Active
Updated
2026-11-06 11:19:12

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
NO
Branded
NO

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRcarbidopa1NAMES
RxNorm Namecarbidopa1NAMES
TTYIN1ATTRIBUTES
SPL_SET_ID
93 linked values
93CODES
UNII_CODEMNX7R8C5VO1CODES
RxCUI20191CODES
MMSL_CODE
3 linked values
3CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CarbidopaCARBIDOPAEdenbridge Pharmaceuticals LLC.55b99f22-9eb2-4df6-9979-bc4c3af5e4542025-12-17Warnings, Adverse reactionsName fallback
generic name: CARBIDOPA
CARBIDOPACARBIDOPAZydus Lifesciences Limited83012ccc-aba2-45bb-9326-dc30cdeb4e3b2024-11-26Name fallback
generic name: CARBIDOPA
CarbidopaCARBIDOPALupin Pharmaceuticals,Inc.e95b1ab8-0fd9-4399-897a-5ae73b36af452024-01-30Warnings, Adverse reactionsName fallback
generic name: CARBIDOPA
CARBIDOPACARBIDOPAZydus Pharmaceuticals USA Inc.c0b1ef99-3092-431a-8fb6-897affd525952023-09-16Warnings, Adverse reactionsName fallback
generic name: CARBIDOPA
CarbidopaCARBIDOPANorthStar Rx LLC33ee4598-cbcc-45e0-a48e-dc0101e1f2042022-11-03Warnings, Adverse reactionsName fallback
generic name: CARBIDOPA
CarbidopaCARBIDOPAAurobindo Pharma Limiteded98c7e1-78a6-43a5-92cd-4f085af6f09d2021-04-29Warnings, Adverse reactionsName fallback
generic name: CARBIDOPA
LodosynCARBIDOPABausch Health US, LLCff8e105b-7415-42d4-bbb2-b36cfb8945a52020-07-01Warnings, Adverse reactionsName fallback
generic name: CARBIDOPA
CarbidopaCARBIDOPANovel Laboratories, Inc.7e5c9666-7a7c-4b64-87e4-7be6ae53603e2017-06-01Warnings, Adverse reactionsName fallback
generic name: CARBIDOPA

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
FDASPLN0000175754Aromatic Amino Acid Decarboxylation InhibitorEPChas_epccarbidopa
FDASPLN0000175755DOPA Decarboxylase InhibitorsMOAhas_moacarbidopa
MEDRTD002230CarbidopaCHEMhas_ingredientcarbidopa
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbidopa anhydrous
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbidopa
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbidopa anhydrous
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbidopa
MEDRTD008545MelanomaDISEASEci_withcarbidopa anhydrous
MEDRTD008545MelanomaDISEASEci_withcarbidopa
MEDRTD010300Parkinson DiseaseDISEASEmay_treatcarbidopa
MEDRTD010300Parkinson DiseaseDISEASEmay_treatcarbidopa anhydrous
MEDRTD010300Parkinson DiseaseDISEASEmay_treatfoscarbidopa
MEDRTN0000175755DOPA Decarboxylase InhibitorsMOAhas_moafoscarbidopa
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moacarbidopa anhydrous
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moacarbidopa
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moafoscarbidopa
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacarbidopa
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacarbidopa anhydrous
MEDRTN0000000133Enzyme InhibitorsMOAhas_moafoscarbidopa
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbidopa anhydrous
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbidopa
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moafoscarbidopa
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pecarbidopa anhydrous
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pecarbidopa
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pefoscarbidopa

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESDRUGBANKDB00190
CODESSNOMEDCT386107009
CODESSNOMEDCT73579000
CODESUSPm12810
CODESVUID4017949
SOURCESSourceDrug Bank
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUnited States Pharmacopeia
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File